Akebia Therapeutics Inc.

(AKBA) Trade

By |

Profile

Akebia Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.

Contact Information

Website: www.akebia.com
Email: david@argotpartners.com
Main Phone: +1 617 871-2098
Address: 245 First Street
Address 2: Suite 1100
State: MA
City / Town: Cambridge
Country: USA
Postal Code: 02142

Issuer Information

Exchange: NSD
Employees: 64
NAICS: Pharmaceutical P
$ 17.67 $ -0.21 (-1.17%)
Last Price 17.67 Change $ -0.21 Change % -1.17 Tick N/A
Bid 11.15 Bid Size 100.00 Ask N/A Ask Size 0.00
Open 17.86 High 17.89 Low 17.57 Prev Close 17.88
Last Trade Volume 251,480 52 Wk Hi 20.25 52 Wk Low 7.16
Market Cap 833.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 47,151,429.00 EPS (TTM) -3.63 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 13
Number of Buys 0 5
Number of Sells 3 8
Net Activity -4939 223313
Last 10 Buys Shares
Muneer Satter 1,000
John P. Butler 1,000
John P. Butler 1,000
Jason A. Amello 1,000
Muneer Satter 1,000
Muneer Satter 1,000
Muneer Satter 1,000
Muneer Satter 1,000
Muneer Satter 1,000
Muneer Satter 1,000
Last 10 Sell Shares
Duane D. Nash 1,000
Nicole R. Hadas 1,000
Michel Dahan 1,000
Michel Dahan 1,000
Nicole R. Hadas 1,000
Nicole R. Hadas 1,000
Duane D. Nash 1,000
Nicole R. Hadas 1,000
Nicole R. Hadas 1,000
Duane D. Nash 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 26 26 26 26
Low Target Price Estimate 14 14 14 14
Mean Target Price Estimate 18.5 18.5 18.5 18.5
Standard Deviation 5.2 5.2 5.2 5.2
Date of Most Recent Estimate 08/11/16 05/16/16 05/16/16 08/11/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 3
Moderate Buy 2 2 2 2
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.38 1.38 1.38 1.3